| Serial Number | 90157600 |
| Word Mark | EKSTERMED |
| Filing Date | Thursday, September 3, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, May 27, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, February 23, 2021 |
| Description of Mark | The mark consists of the word, "EksterMed" with "Ekster" in dark blue and "Med" in lighter blue. Above the wording is a design consisting of seventy-five small circles lined both horizontally and vertically, forming a shape of a plus symbol. The size of the circles is large in the inner part and dark blue and the circles become light blue and smaller toward the outer part. |
| Goods and Services | Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions |
| Goods and Services | Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; non-medicated soaps for personal use; perfumery; essential oils; hair lotions |
| Indication of Colors claimed | The color(s) light blue and dark blue is/are claimed as a feature of the mark. |
| International Class | 003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. |
| US Class Codes | 001, 004, 006, 050, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 8, 2020 |
| Primary Code | 003 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 8, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Teikoku Pharma USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Jose, CA 95131 |
| Party Name | Teikoku Pharma USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Jose, CA 95131 |
| Event Date | Event Description |
| Monday, September 7, 2020 | NEW APPLICATION ENTERED |
| Thursday, October 8, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 9, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, January 14, 2021 | ASSIGNED TO LIE |
| Thursday, January 14, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Friday, January 8, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, January 13, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, January 13, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 13, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, January 15, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 3, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 23, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 23, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, October 18, 2021 | SOU EXTENSION 1 FILED |
| Monday, October 25, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, October 26, 2021 | SOU EXTENSION 1 GRANTED |
| Wednesday, October 27, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, April 20, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, October 18, 2021 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 15, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 15, 2022 | SOU EXTENSION 2 FILED |
| Friday, April 15, 2022 | SOU EXTENSION 2 GRANTED |
| Tuesday, April 19, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, October 17, 2022 | SOU EXTENSION 3 FILED |
| Monday, October 17, 2022 | SOU EXTENSION 3 GRANTED |
| Wednesday, October 19, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, April 17, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, October 16, 2023 | SOU EXTENSION 5 FILED |
| Wednesday, October 18, 2023 | SOU EXTENSION 5 GRANTED |
| Thursday, October 19, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, October 17, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, April 17, 2023 | SOU EXTENSION 4 FILED |
| Monday, April 17, 2023 | SOU EXTENSION 4 GRANTED |
| Wednesday, April 19, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, October 16, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, May 27, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, July 12, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |